Drug Trial Radar · NCT04468100
Efficacy and Safety of Tigerase® vs. Pulmozyme® in Patients With Cystic Fibrosis
Last checked: Nov 20, 2026Latest source record: Jul 13, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
100
Actual
Start
Aug 30, 2017
Primary completion
May 16, 2018
Study completion May 16, 2018
Sponsor
- Lead sponsor
- AO GENERIUMIndustry
- Sponsor type
- Industry
- First posted
- Jul 13, 2020
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
It is a multicenter, open-label, randomized, parallel-group study of the efficacy and safety of Tigerase® compared Pulmozyme® in patients with Cystic Fibrosis
Conditions
- Cystic Fibrosis
- Fibrosis
Interventions
Tigerase®Biological
2.5 mL (2.5 mg) dornase alfa nebulized once daily for 168 (+/-7) days
Pulmozyme®Biological
2.5 mL (2.5 mg) dornase alfa nebulized once daily for 168 (+/-7) days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change in forced expiratory volume in the first second of a forced expiratory maneuver (FEV1) compared to baselineTime frame: FEV1 - forced expiratory volume in the first second of a forced expiratory maneuver by standard spirometry
Locations
14 sites in 1 country. Site status is shown where the registry gives one.
Chelyabinsk Regional Clinical hospital
Chelyabinsk, Russia
City Clinical Hospital named after D.D. Pletnev
Moscow, Russia
City Multidisciplinary Hospital No. 2
Saint Petersburg, Russia
Regional clinical Hospital
Saratov, Russia
Scientific medical center of General Medicine and pharmacologies
Stavropol, Russia
Tomsk national medical research Center of the Russian Academy of Sciences, Genetic Clinic Research Institute medical genetics
Tomsk, Russia
Volgograd State Medical University, Department of clinical pharmacology and intensive care
Volgograd, Russia
Children's Clinical Hospital No. 1 ", Cystic Fibrosis center
Yaroslavl, Russia
Clinical hospital No. 2
Yaroslavl, Russia
Regional Clinical Hospital
Barnaul, Altayskiy Kray, Russia
Republican Clinical hospital named after G.G. Kuvatov
Ufa, Bashkortostan Republic, Russia
Crimean federal university named after V.I.Vernadsky
Simferopol, Crimea Republic, Russia
Sverdlovsk Regional clinical hospital No. 1
Yekaterinburg, Sverdlovsk Oblast, Russia
Kazan state medical University of Ministry of health, Hospital Therapy Department
Kazan', Tatarstan Republic, Russia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.